Literature DB >> 17944632

Pre-treatment with hyperoxia before coronary artery bypass grafting - effects on myocardial injury and inflammatory response.

I Karu1, R Loit, K Zilmer, C Kairane, A Paapstel, M Zilmer, J Starkopf.   

Abstract

BACKGROUND: In experimental studies, exposure to hyperoxia for a limited time before ischaemia induces a low-grade systemic oxidative stress and evokes an (ischaemic) preconditioning-like effect of the myocardium. We hypothesised that hyperoxia before cardioplegia could protect the myocardium against necrosis and stunning caused by ischaemia-reperfusion.
METHODS: Forty patients undergoing coronary artery bypass grafting were randomly exposed to an oxygen fraction of 0.4 or > 0.96 in inspired air on an average of 120 min before cardioplegia. Blood for troponin I, creatine kinase-MB, lactate, glutathione and interleukin-6 was sampled from arterial and coronary sinus cannulae during 20 min of reperfusion. Additional arterial samples were drawn 60 min after declamping and in the first post-operative morning. The cardiac index and right and left ventricular stroke work indices were measured before sternotomy and up to 12 h post-operatively.
RESULTS: Troponin I, creatine kinase-MB and lactate did not differ between the groups. Hyperoxic pre-treatment had no impact on the post-operative haemodynamic indices measured with the thermodilution pulmonary artery catheter. More oxidised glutathione was released in the hyperoxia group in the first minute of reperfusion (P = 0.015). Hyperoxic pre-treatment abolished the myocardial release of interleukin-6 during 20 min of reperfusion (P = 0.021 vs. controls). In the first post-operative morning, interleukin-6 was higher in the hyperoxia group [127.0 (86.0-140.0) vs. 85.2 pg/ml (66.6-94.5 pg/ml); P = 0.016].
CONCLUSIONS: Exposure to >96% oxygen before cardioplegia did not attenuate ischaemia-reperfusion injury of the heart in patients undergoing coronary artery bypass grafting. The only potentially beneficial effect observed was the decreased transmyocardial release of interleukin-6.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17944632     DOI: 10.1111/j.1399-6576.2007.01444.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  7 in total

Review 1.  The effects of high perioperative inspiratory oxygen fraction for adult surgical patients.

Authors:  Jørn Wetterslev; Christian S Meyhoff; Lars N Jørgensen; Christian Gluud; Jane Lindschou; Lars S Rasmussen
Journal:  Cochrane Database Syst Rev       Date:  2015-06-25

Review 2.  Year in Review 2021: Noteworthy Literature in Cardiothoracic Anesthesia.

Authors:  Aaron Smoroda; David Douin; Joseph Morabito; Matthew Lyman; Meghan Prin; Bryan Ahlgren; Andrew Young; Elijah Christensen; Benjamin A Abrams; Nathaen Weitzel; Nathan Clendenen
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2022-05-17

Review 3.  Effects of Hyperoxia on Aging Biomarkers: A Systematic Review.

Authors:  Belay Tessema; Ulrich Sack; Zoya Serebrovska; Brigitte König; Egor Egorov
Journal:  Front Aging       Date:  2022-01-03

4.  Effects of 60 minutes of hyperoxia followed by normoxia before coronary artery bypass grafting on the inflammatory response profile and myocardial injury.

Authors:  Inga Karu; Peeter Tähepõld; Arno Ruusalepp; Kersti Zilmer; Mihkel Zilmer; Joel Starkopf
Journal:  J Negat Results Biomed       Date:  2012-09-14

5.  Moderate hyperoxic versus near-physiological oxygen targets during and after coronary artery bypass surgery: a randomised controlled trial.

Authors:  Bob Smit; Yvo M Smulders; Monique C de Waard; Christa Boer; Alexander B A Vonk; Dennis Veerhoek; Suzanne Kamminga; Harm-Jan S de Grooth; Juan J García-Vallejo; Rene J P Musters; Armand R J Girbes; Heleen M Oudemans-van Straaten; Angelique M E Spoelstra-de Man
Journal:  Crit Care       Date:  2016-03-10       Impact factor: 9.097

6.  Short-term hyperoxia does not exert immunologic effects during experimental murine and human endotoxemia.

Authors:  Dorien Kiers; Jelle Gerretsen; Emmy Janssen; Aaron John; R Groeneveld; Johannes G van der Hoeven; Gert-Jan Scheffer; Peter Pickkers; Matthijs Kox
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

7.  miR-142-5p regulates CD4+ T cells in human non-small cell lung cancer through PD-L1 expression via the PTEN pathway.

Authors:  Jun Wan; Xiean Ling; Bin Peng; Guanggui Ding
Journal:  Oncol Rep       Date:  2018-05-16       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.